The relevance of the BRCA1/BARD1 ubiquitin E3 activity for HR in terms of DNA DSB repair and treatment resistance remains contradictory in current literature, due to the use of different approaches involving diverse cancer cell lines and models2,10,11,19,20. The gene discussed is BARD1; the disease is cancer.